Tung Roger D
- SEC CIK
- 0001594857
No open-market purchases or sales filed in the past year.
Current role at each company
- CNCE Concert Pharmaceuticals, Inc.Chief Executive Officeras of Mar 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tung Roger D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 (view filing) | Jan 6 | 3 days | Tung Roger DChief Executive Officer | SSale | −9.24K | $7.24 | −$66.9K | −0.9%971.0K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Tung Roger DChief Executive Officer | SSale | −13.5K | $3.09 | −$41.7K | −1.4%980.3K after | |
| Jan 7, 2022 (view filing) | Jan 6 | 1 day | Tung Roger DChief Executive Officer | SSale | −9.24K | $3.09 | −$28.6K | −1.2%784.8K after | |
| Dec 15, 2021 (view filing) | Dec 13 | 2 days | Tung Roger DChief Executive Officer | SSale | −6.70K | $3.62 | −$24.3K | −0.8%808.6K after |